Gillard, Baiba

Publications

Sort by

Co-Author Network

selected publications

Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability. Methodist DeBakey cardiovascular journal. 2019 Information Resource GET IT
Times cited: 18
Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research. Arteriosclerosis, thrombosis, and vascular biology. 2018 Academic Article GET IT
Times cited: 61
Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins. Journal of clinical lipidology. 2018 Information Resource GET IT
Times cited: 37
Structural Stability of Streptococcal Serum Opacity Factor. The protein journal. 2017 Academic Article GET IT
Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester. The Journal of biological chemistry. 2017 Academic Article GET IT
Times cited: 30
Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease. Scientific reports. 2017 Academic Article GET IT
Times cited: 78
Neo High-Density Lipoprotein Produced by the Streptococcal Serum Opacity Factor Activity against Human High-Density Lipoproteins Is Hepatically Removed via Dual Mechanisms. Biochemistry. 2016 Academic Article GET IT
Times cited: 2
Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo. Biochimica et biophysica acta. 2016 Academic Article GET IT
Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism. Methodist DeBakey cardiovascular journal. 2016 Information Resource GET IT
Times cited: 17
Speciated High-Density Lipoprotein Biogenesis and Functionality. Current atherosclerosis reports. 2016 Information Resource GET IT
Times cited: 6
Direct Measurement of the Structure of Reconstituted High-Density Lipoproteins by Cryo-EM. Biophysical journal. 2015 Academic Article GET IT
Times cited: 13
Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo. Biochimica et biophysica acta. 2015 Academic Article GET IT
Times cited: 5
Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism. Biochemistry. 2015 Academic Article GET IT
Times cited: 5
Alcohol: a nutrient with multiple salutary effects. Nutrients. 2015 Information Resource GET IT
Times cited: 9
Setting the course for apoAII: a port in sight?. Clinical lipidology. 2013 Academic Article GET IT
Free cholesterol determines reassembled high-density lipoprotein phospholipid phase structure and stability. Biochemistry. 2013 Academic Article GET IT
Times cited: 7
Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients. Medicine and science in sports and exercise. 2013 Academic Article GET IT
Times cited: 21
Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome. Journal of clinical lipidology. 2013 Academic Article GET IT
Times cited: 20
Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function. Arteriosclerosis, thrombosis, and vascular biology. 2013 Academic Article GET IT
Times cited: 26
Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients. Metabolism: clinical and experimental. 2013 Academic Article GET IT
Times cited: 22
Cholesterol determines and limits rHDL formation from human plasma apolipoprotein A-II and phospholipid membranes. Biochemistry. 2012 Academic Article GET IT
Times cited: 9
Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo. Arteriosclerosis, thrombosis, and vascular biology. 2011 Academic Article GET IT
Times cited: 22
Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol. Biochemistry. 2010 Academic Article GET IT
Times cited: 15
Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects. Lipids. 2010 Academic Article GET IT
Times cited: 10
HDL superphospholipidation enhances key steps in reverse cholesterol transport. Atherosclerosis. 2009 Academic Article GET IT
Times cited: 32
Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins. Biochemistry. 2009 Academic Article GET IT
Times cited: 18
Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells. Biochimica et biophysica acta. 2009 Academic Article GET IT
Times cited: 37
Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I. Biochemistry. 2009 Academic Article GET IT
Times cited: 20
Properties of the products formed by the activity of serum opacity factor against human plasma high-density lipoproteins. Chemistry and physics of lipids. 2008 Academic Article GET IT
Times cited: 6
Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption. Biochemistry. 2007 Academic Article GET IT
Times cited: 41
Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning. Biochemistry. 2007 Academic Article GET IT
Times cited: 40
Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A(2). Journal of lipid research. 2006 Academic Article GET IT
Times cited: 50
N-Glycosylation is required for secretion-competent human plasma phospholipid transfer protein. The protein journal. 2006 Academic Article GET IT
Times cited: 4
Plasma factors required for human apolipoprotein A-II dimerization. Biochemistry. 2005 Academic Article GET IT
Times cited: 11
Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways. Glycobiology. 1998 Academic Article GET IT
Times cited: 82
Decreased synthesis of glycosphingolipids in cells lacking vimentin intermediate filaments. Experimental cell research. 1998 Academic Article GET IT
Times cited: 51
Pathways of glycosphingolipid biosynthesis in SW13 cells in the presence and absence of vimentin intermediate filaments. Glycobiology. 1996 Academic Article GET IT
Times cited: 28
Biosynthesis of glycosphingolipids is reduced in the absence of a vimentin intermediate filament network. Journal of cell science. 1994 Academic Article GET IT
Times cited: 34
Human milk oligosaccharides. Acta paediatrica (Oslo, Norway : 1992). 1994 Article GET IT
Times cited: 3
Variable subcellular localization of glycosphingolipids. Glycobiology. 1993 Academic Article GET IT
Times cited: 68
Biosynthesis of the blood group Pk and P1 antigens by human kidney microsomes. Carbohydrate research. 1992 Academic Article GET IT
Times cited: 12
Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells. Cell motility and the cytoskeleton. 1992 Academic Article GET IT
Times cited: 62
Subpopulations of B cells in germinal centers. III. HJ6, a monoclonal antibody, binds globoside and a subpopulation of germinal center B cells. Journal of immunology (Baltimore, Md. : 1950). 1991 Academic Article GET IT
Times cited: 18
Association of glycosphingolipids with intermediate filaments of human umbilical vein endothelial cells. Experimental cell research. 1991 Academic Article GET IT
Times cited: 57
Interferon-gamma alters expression of endothelial cell-surface glycosphingolipids. Archives of biochemistry and biophysics. 1990 Academic Article GET IT
Times cited: 29
Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus. Journal of immunology (Baltimore, Md. : 1950). 1989 Academic Article GET IT
Times cited: 80
Molecular characterization of human X/Y translocations suggests their aetiology through aberrant exchange between homologous sequences on Xp and Yq. Annals of human genetics. 1989 Academic Article GET IT
Times cited: 24
Structure of a ganglioside with Cad blood group antigen activity. Biochemistry. 1988 Academic Article GET IT
Times cited: 13
Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells. Archives of biochemistry and biophysics. 1987 Academic Article GET IT
Times cited: 48
Isolation and purification of gangliosides from plasma. Methods in enzymology. 1987 Academic Article GET IT
Times cited: 38
Three methods compared for determination of pancreatic and salivary amylase activity in serum of cystic fibrosis patients. Clinical chemistry. 1986 Academic Article GET IT
Times cited: 4
Identification of a novel ganglioside on erythrocytes with blood group Cad specificity. The Journal of biological chemistry. 1985 Academic Article GET IT
Times cited: 27
A solvent partition method for microscale ganglioside purification. Analytical biochemistry. 1985 Academic Article GET IT
Times cited: 168
Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro. The Journal of clinical investigation. 1984 Academic Article GET IT
Times cited: 99
Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function. Pediatric research. 1984 Academic Article GET IT
Times cited: 24
Cystic fibrosis serum pancreatic amylase. Useful discriminator of exocrine function. American journal of diseases of children (1960). 1984 Academic Article GET IT
Times cited: 7
Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer research. 1983 Academic Article GET IT
Times cited: 179
Reference intervals for amylase isoenzymes in serum and plasma of infants and children. Clinical chemistry. 1983 Academic Article GET IT
Times cited: 24
Serum amylase isoenzymes in cystic fibrosis patients. Evidence for a generalized defect in exocrine gland secretory regulation. Pediatric research. 1980 Academic Article GET IT
Times cited: 8
Amylo-1,6-glucosidase/4-alpha-glucanotransferase. Reaction of rabbit muscle debranching enzyme with an active site-directed irreversible inhibitor, 1-S-dimethylarsino-1-thio-beta-D-glucopyranoside. The Journal of biological chemistry. 1980 Academic Article GET IT
Times cited: 12
Quantitative gel-electrophoretic determination of serum amylase isoenzyme distributions. Clinical chemistry. 1979 Academic Article GET IT
Times cited: 14
Differences between cystic fibrosis and normal saliva alpha-amylase as a function of age and sex. Pediatric research. 1978 Academic Article GET IT
Times cited: 4
Direct spectrophotometric determination of alpha-amylase activity in salive, with p-nitrophenyl alpha-maltoside as substrate. Clinical chemistry. 1977 Academic Article GET IT
Times cited: 28
Amylo-1,6-glucosidase/4-alpha-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme. Biochemistry. 1977 Academic Article GET IT
Times cited: 43
Cystic fibrosis: enzymatic detection of a ciliostatic factor. Pediatric research. 1976 Academic Article GET IT
Times cited: 8

more ...

less ...

Background

education and training

Ph.D., Washington University in St. Louis 1972
M.A., Washington University in St. Louis 1969
B.S., Purdue University 1967

Contact

full name

Baiba Gillard

VIVO Weill Cornell Medical College

Baiba Gillard Associate Professor of Biochemistry Research in Cardiothoracic Surgery

Publications

selected publications

Background

education and training

Contact

full name